149 related articles for article (PubMed ID: 17485506)
1. Differentially expressed proteins in derivatives of Candida albicans displaying a stable histatin 3-resistant phenotype.
Fitzgerald-Hughes DH; Coleman DC; O'Connell BC
Antimicrob Agents Chemother; 2007 Aug; 51(8):2793-800. PubMed ID: 17485506
[TBL] [Abstract][Full Text] [Related]
2. Binding, internalisation and degradation of histatin 3 in histatin-resistant derivatives of Candida albicans.
Fitzgerald DH; Coleman DC; O'Connell BC
FEMS Microbiol Lett; 2003 Mar; 220(2):247-53. PubMed ID: 12670688
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis reveals a metabolism shift in a laboratory fluconazole-resistant Candida albicans strain.
Yan L; Zhang JD; Cao YB; Gao PH; Jiang YY
J Proteome Res; 2007 Jun; 6(6):2248-56. PubMed ID: 17432892
[TBL] [Abstract][Full Text] [Related]
4. Proteomic and metabolic characterization of a Candida albicans mutant resistant to the antimicrobial peptide MUC7 12-mer.
Lis M; Bobek LA
FEMS Immunol Med Microbiol; 2008 Oct; 54(1):80-91. PubMed ID: 18680518
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Candida albicans growth by brominated furanones.
Duo M; Zhang M; Luk YY; Ren D
Appl Microbiol Biotechnol; 2010 Feb; 85(5):1551-63. PubMed ID: 19756586
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of Candida biofilms to histatin 5 and fluconazole.
Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N
Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514
[TBL] [Abstract][Full Text] [Related]
7. An acquired mechanism of antifungal drug resistance simultaneously enables Candida albicans to escape from intrinsic host defenses.
Hampe IAI; Friedman J; Edgerton M; Morschhäuser J
PLoS Pathog; 2017 Sep; 13(9):e1006655. PubMed ID: 28953977
[TBL] [Abstract][Full Text] [Related]
8. Internalisation and degradation of histatin 5 by Candida albicans.
Ruissen AL; Groenink J; Krijtenberg P; Walgreen-Weterings E; van 't Hof W; Veerman EC; Nieuw Amerongen AV
Biol Chem; 2003 Jan; 384(1):183-90. PubMed ID: 12674513
[TBL] [Abstract][Full Text] [Related]
9. Genetically engineered human salivary histatin genes are functional in Candida albicans: development of a new system for studying histatin candidacidal activity.
Baev D; Li X; Edgerton M
Microbiology (Reading); 2001 Dec; 147(Pt 12):3323-34. PubMed ID: 11739764
[TBL] [Abstract][Full Text] [Related]
10. Killing of Candida albicans by histatin 5: cellular uptake and energy requirement.
Gyurko C; Lendenmann U; Helmerhorst EJ; Troxler RF; Oppenheim FG
Antonie Van Leeuwenhoek; 2001 Sep; 79(3-4):297-309. PubMed ID: 11816973
[TBL] [Abstract][Full Text] [Related]
11. Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans.
Sigle HC; Thewes S; Niewerth M; Korting HC; Schäfer-Korting M; Hube B
J Antimicrob Chemother; 2005 May; 55(5):663-73. PubMed ID: 15790671
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of ERG11 gene among fluconazole-resistant Candida albicans generated in vitro: is there any clinical implication?
Ribeiro MA; Paula CR
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):71-5. PubMed ID: 16839736
[TBL] [Abstract][Full Text] [Related]
13. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
Niimi M; Niimi K; Takano Y; Holmes AR; Fischer FJ; Uehara Y; Cannon RD
J Antimicrob Chemother; 2004 Dec; 54(6):999-1006. PubMed ID: 15486081
[TBL] [Abstract][Full Text] [Related]
14. Saliva affects the antifungal activity of exogenously added histatin 3 towards Candida albicans.
Yamagishi H; Fitzgerald DH; Sein T; Walsh TJ; O'Connell BC
FEMS Microbiol Lett; 2005 Mar; 244(1):207-12. PubMed ID: 15727842
[TBL] [Abstract][Full Text] [Related]
15. Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans.
Chen CG; Yang YL; Tseng KY; Shih HI; Liou CH; Lin CC; Lo HJ
Fungal Genet Biol; 2009 Sep; 46(9):714-20. PubMed ID: 19527793
[TBL] [Abstract][Full Text] [Related]
16. [Study on experimental induction of fluconazole resistance in Candida albicans].
Zhu YN; Lu SM
Shi Yan Sheng Wu Xue Bao; 2004 Oct; 37(5):418-22. PubMed ID: 15636370
[TBL] [Abstract][Full Text] [Related]
17. Upc2p-associated differential protein expression in Candida albicans.
Hoehamer CF; Cummings ED; Hilliard GM; Morschhäuser J; David Rogers P
Proteomics; 2009 Oct; 9(20):4726-30. PubMed ID: 19750515
[TBL] [Abstract][Full Text] [Related]
18. RTA2, a novel gene involved in azole resistance in Candida albicans.
Jia XM; Ma ZP; Jia Y; Gao PH; Zhang JD; Wang Y; Xu YG; Wang L; Cao YY; Cao YB; Zhang LX; Jiang YY
Biochem Biophys Res Commun; 2008 Sep; 373(4):631-6. PubMed ID: 18601908
[TBL] [Abstract][Full Text] [Related]
19. Candida albicans mutants deficient in respiration are resistant to the small cationic salivary antimicrobial peptide histatin 5.
Gyurko C; Lendenmann U; Troxler RF; Oppenheim FG
Antimicrob Agents Chemother; 2000 Feb; 44(2):348-54. PubMed ID: 10639361
[TBL] [Abstract][Full Text] [Related]
20. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
